BCRX   $7.62  1.74% Market Closed After Close 7.6 -0.26%

BioCryst Pharmaceuticals Inc
Total Cash 272.03M
totalCashPerShare 1.313
EBITDA -31.92M
Total Debt 850.64M
quickRatio
currentRatio
Total Revenue 412.58M
debtToEquity
Revenue/Share 2.01
ROA
ROE
grossProfits
freeCashflow
operatingCashflow
earningsGrowth
revenueGrowth 0.35
grossMargins 0.52154
ebitdaMargins -0.077360004
operatingMargins 0.0657
profitMargins -0.3001
enterpriseValue 2.18B
forwardPE -128.83334
floatShares 192.62M
sharesOutstanding 207.13M
sharesShort 22.53M
sharesShortPriorMonth 24.32M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.87%
Short Ratio help_outline 12.75%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue -2.302
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -123.82M
trailingEps -0.67%
forwardEps -0.06%
enterpriseToEbitda -68.29
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 4Q 2024
institutionsCount 327
lastUpdated Nov. 7, 2024, 9:20 a.m.